Skip to content

Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study.

Randomized controlled trial · Psychogeriatrics · 2024. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 38439118

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy and safety of donepezil in patients with dementia with Lewy bodies: results from a 12-week multicentre, randomised, double-blind, and placebo-controlled phase IV study.

Mori E, Ikeda M, Iseki E et al.
Psychogeriatrics · 2024

PubMed ID
38439118
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.